Amoéba reported consolidated earnings results for the first half ended June 30, 2017. For the period, the company reported turnover of EUR 75,000 compared to EUR 60,000 a year ago. Operational balance was negative of EUR 3,144,000 compared to EUR 2,672,000 a year ago. Net balance was negative of EUR 3,240,000 compared to EUR 2,688,000 a year ago. A turnover of EUR 75,000 was mainly made up of the half-yearly licence fee paid by AQUAPROX, amounting to EUR 60,000 and the invoicing of industrial R&D tests in Europe for EUR 15,000. Cash flow is EUR 8.6 million.